Viru-Chord

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Viru-Chord
Generic name: BELLADONNA, CINCHONA OFFICINALIS, ECHINACEA (ANGUSTIFOLIA), GELSEMIUM SEMPERVIRENS, GLANDULA SUPRARENALIS SUIS, GLYCYRRHIZA GLABRA, HEPAR SUIS, HYDRASTIS CANADENSIS, ILLICIUM ANISATUM, INFLUENZINUM, LACHESIS MUTUS, LAPPA MAJOR, MAGNESIA PHOSPHORICA, MORBILLINUM, MYRRHA, NASTURTIUM AQUATICUM, NUX VOMICA, PALOONDO, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SAMBUCUS NIGRA, SCUTELLARIA LATERIFLORA, THIAMINUM HYDROCHLORICUM, THYROIDINUM (BOVINE)
Manufacturer: Energetix Corporation
Product type: HUMAN OTC DRUG
SPL set ID: 4a53b25e-f514-4d2d-8c2b-3c56d68ec7eb
SPL ID: 468d2fa2-e38e-e25e-e063-6394a90a220c
Version: 10
Effective date: 2025-12-22
Source export date: 2026-09-28
Source partition: 4
Source file: https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/c7ca0b7091cdaeab3f27713a6eef00adcf8fe722383633ddce61531b4c840544/drug-label-0004-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:27:10

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 37 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Viru-Chord	openfda.brand_name
generic name		BELLADONNA, CINCHONA OFFICINALIS, ECHINACEA (ANGUSTIFOLIA), GELSEMIUM SEMPERVIRENS, GLANDULA SUPRARENALIS SUIS, GLYCYRRHIZA GLABRA, HEPAR SUIS, HYDRASTIS CANADENSIS, ILLICIUM ANISATUM, INFLUENZINUM, LACHESIS MUTUS, LAPPA MAJOR, MAGNESIA PHOSPHORICA, MORBILLINUM, MYRRHA, NASTURTIUM AQUATICUM, NUX VOMICA, PALOONDO, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SAMBUCUS NIGRA, SCUTELLARIA LATERIFLORA, THIAMINUM HYDROCHLORICUM, THYROIDINUM (BOVINE)	openfda.generic_name
manufacturer name		Energetix Corporation	openfda.manufacturer_name
ndc	package	64578-0128-1	openfda.package_ndc
ndc	product	64578-0128	openfda.product_ndc
ndc11	package	64578012801	derived:openfda.package_ndc
spl id		468d2fa2-e38e-e25e-e063-6394a90a220c	id
spl set id		4a53b25e-f514-4d2d-8c2b-3c56d68ec7eb	set_id
unii		445486QJCG	openfda.unii
unii		2788Z9758H	openfda.unii
unii		269XH13919	openfda.unii
unii		HT3R7C012Q	openfda.unii
unii		XKC1657P78	openfda.unii
unii		80T3QS071U	openfda.unii
unii		TLM2976OFR	openfda.unii
unii		3W5C8YUT4D	openfda.unii
unii		639KR60Q1Q	openfda.unii
unii		HF539G9L3Q	openfda.unii
unii		MN18OTN73W	openfda.unii
unii		VB06AV5US8	openfda.unii
unii		ZW3Z11D0JV	openfda.unii
unii		V3EC8AF8MF	openfda.unii
unii		S003A158SB	openfda.unii
unii		7BP4DH5PDC	openfda.unii
unii		WQZ3G9PF0H	openfda.unii
unii		M572600E5P	openfda.unii
unii		398IYQ16YV	openfda.unii
unii		VSW71SS07I	openfda.unii
unii		9VVQ21KI5Z	openfda.unii
unii		CT03BSA18U	openfda.unii
unii		YH89GMV676	openfda.unii
unii		68Y4CF58BV	openfda.unii
unii		KFL1W6W9JB	openfda.unii
unii		6EC706HI7F	openfda.unii
unii		PK0TXD049P	openfda.unii
unii		JC71GJ1F3L	openfda.unii
unii		597E9BI3Z3	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings • In case of overdose, get medical help or contact a Poison Control Center right away. If pregnant or breast feeding, ask a healthcare professional before use. Keep out of reach of children. Take 30 drops orally twice daily or as directed by a healthcare professional. Consult a physician for use in children under 12 years of age or if symptoms worsen or persist.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.